跳至主要内容
临床试验/KCT0001763
KCT0001763招募中未知

Endoscopy (ultrasound endoscopy, retrograde pancreatic endoscopy, percutaneous transhepatic endoscopy) photodynamic therapy using next-generation photosensitizers and laser probes in patients with locally advanced pancreatic and hepatic ductal carcinoma without response to conventional therapy

Asan Medical Center0 个研究点目标入组 65 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 99(Year)(—)
性别
All

入选标准

  • 1) Criteria for selecting pancreatic tumor test subjects
  • ? Stages that can not be operated (stage 3 ~ 4a) or systemic conditions or accompanying diseases
  • ? Pancreatic cancer that progresses locally without systemic metastasis despite conventional chemotherapy
  • ? Under the judgment of the researcher, patients who are deemed to need a new treatment method corresponding to 1) and 2)
  • ? Those diagnosed as adenocarcinoma histologically from pancreatic cancer
  • ? Women who were not menopausal or sterilized were tested for serum
  • ß-HCG negative can be used, and medically acceptable contraceptive methods should be used
  • ? The Eastern Cooperative Oncology Group (ECOG)
  • ? Patients aged 19 or older who understood and agreed to this study
  • 2) Criteria for selection of candidates for liver cancer
  • ? Cholangiocarcinoma patients who need broad-band cure
  • ? Those who are unable to perform surgery due to systemic conditions or accompanying diseases.
  • ? Cholangiocarcinoma progressing locally without systemic metastasis despite conventional chemotherapy
  • ? Under the judgment of the researcher, patients who are deemed to need a new treatment corresponding to 1) and 2)
  • ? Patients aged 19 or older who understood and agreed to this study

排除标准

  • 1) criteria for excluding pancreatic tumor test subjects
  • ? Under 18 years old
  • ? If you can not perform endoscopic ultrasound under sedation
  • ? The subject who had previously received PDT for the pancreas
  • ? hemorrhagic tendency, or those with related diseases or the following laboratory
  • If you have a number
  • - PT INR> 1.5
  • - platelet <50,000
  • - WBC <2.0x10? / l
  • - hemoglobin <90 g / l
  • - Hematocrit ratio <27%
  • ? Those who have acute pancreatitis accompanied by a screening criterion within 4 weeks
  • ? If there is no willingness to follow up or if the patient does not agree with the procedure
  • ? pregnant or lactating
  • ? Those participating in other drug clinical trials before 30 days on screening basis. However,
  • Participating subjects can be registered
  • ? Candidates who have known hypersensitivity to known porphyria
  • ? If there are other neoplasms other than cervical intraepithelial carcinoma or skin basal cell carcinoma,
  • Subjects with a history of other neoplasms treated within 5 years
  • ? Intermediate-level dysfunction with a parameter of grade 3 or higher according to the adverse reaction term standard.
  • ? Cockcroft-Gault equation with calculated creatinine clearance <45 ml
  • ? If the Eastern Cooperative Oncology Group (ECOG) Score is more than 3 levels
  • ? Others Those who are deemed difficult to perform the clinical trial when the test taker judges
  • 2) Criteria for excluding patients to be tested for cholangiocarcinoma
  • ? Under 18 years old
  • ? If you can not perform endoscopic ultrasound under sedation
  • ? Uncorrected coagulation disorder (PT INR> 1.5, platelet <50,000)
  • ? Those with acute pancreatitis
  • ? If there is no willingness to follow up or if the patient does not agree with the procedure

研究者

相似试验

Endoscopy (ultrasound endoscopy, retrograde... | 临床试验